US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 20.690
  • +0.420+2.07%
Close Mar 11 16:00 ET
  • 20.690
  • 0.0000.00%
Post 16:05 ET
1.01BMarket Cap-11.48P/E (TTM)

Enliven Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
11.63%27.07M
22.20%24.6M
58.28%25.99M
115.33%83.53M
123.64%22.73M
121.77%24.25M
123.31%20.13M
89.19%16.42M
56.66%38.79M
21.06%10.16M
Selling and administrative expenses
25.16%5.81M
16.68%5.78M
32.59%6.02M
143.98%18.96M
145.37%4.82M
49.50%4.64M
358.85%4.95M
180.30%4.54M
81.18%7.77M
28.41%1.97M
-General and administrative expense
25.16%5.81M
16.68%5.78M
32.59%6.02M
143.98%18.96M
145.37%4.82M
49.50%4.64M
358.85%4.95M
180.30%4.54M
81.18%7.77M
28.41%1.97M
Research and development costs
8.43%21.26M
23.99%18.83M
68.10%19.97M
108.16%64.57M
118.43%17.91M
150.43%19.61M
91.29%15.18M
68.30%11.88M
51.52%31.02M
19.42%8.2M
Operating profit
-11.63%-27.07M
-22.20%-24.6M
-58.28%-25.99M
-115.33%-83.53M
-123.64%-22.73M
-121.77%-24.25M
-123.31%-20.13M
-89.19%-16.42M
-56.66%-38.79M
-21.06%-10.16M
Net non-operating interest income expense
9.94%3.84M
19.72%4.09M
91.85%3.25M
959.96%11.97M
449.43%3.37M
818.95%3.49M
2,587.40%3.41M
18,722.22%1.69M
5,031.82%1.13M
20,333.33%613K
Non-operating interest income
9.94%3.84M
19.72%4.09M
91.85%3.25M
959.96%11.97M
449.43%3.37M
818.95%3.49M
2,587.40%3.41M
18,722.22%1.69M
5,031.82%1.13M
20,333.33%613K
Other net income (expense)
661.54%73K
799K
-1K
-22K
-9K
-13K
Special income (charges)
--73K
--800K
----
----
----
--0
--0
----
----
----
-Less：Restructuring and merger&acquisition
---73K
---800K
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
----
---1K
---1K
---22K
---9K
---13K
----
----
----
----
Income before tax
-11.49%-23.16M
-17.92%-19.72M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
-52.23%-37.66M
-13.80%-9.55M
Income tax
0
232K
0
0
Net income
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
-52.23%-37.66M
-13.80%-9.55M
Net income continuous Operations
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
-52.23%-37.66M
-13.80%-9.55M
Minority interest income
Net income attributable to the parent company
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
-52.23%-37.66M
-13.80%-9.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
-52.23%-37.66M
-13.80%-9.55M
Basic earnings per share
5.88%-0.48
0.00%-0.41
32.50%-0.54
-119.35%-2.01
-97.97%-0.46
-98.61%-0.51
-89.57%-0.41
-279.28%-0.8
-52.23%-0.9164
-13.80%-0.2324
Diluted earnings per share
5.88%-0.48
0.00%-0.41
32.50%-0.54
-119.35%-2.01
-97.97%-0.46
-98.61%-0.51
-89.57%-0.41
-279.28%-0.8
-52.23%-0.9164
-13.80%-0.2324
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 11.63%27.07M22.20%24.6M58.28%25.99M115.33%83.53M123.64%22.73M121.77%24.25M123.31%20.13M89.19%16.42M56.66%38.79M21.06%10.16M
Selling and administrative expenses 25.16%5.81M16.68%5.78M32.59%6.02M143.98%18.96M145.37%4.82M49.50%4.64M358.85%4.95M180.30%4.54M81.18%7.77M28.41%1.97M
-General and administrative expense 25.16%5.81M16.68%5.78M32.59%6.02M143.98%18.96M145.37%4.82M49.50%4.64M358.85%4.95M180.30%4.54M81.18%7.77M28.41%1.97M
Research and development costs 8.43%21.26M23.99%18.83M68.10%19.97M108.16%64.57M118.43%17.91M150.43%19.61M91.29%15.18M68.30%11.88M51.52%31.02M19.42%8.2M
Operating profit -11.63%-27.07M-22.20%-24.6M-58.28%-25.99M-115.33%-83.53M-123.64%-22.73M-121.77%-24.25M-123.31%-20.13M-89.19%-16.42M-56.66%-38.79M-21.06%-10.16M
Net non-operating interest income expense 9.94%3.84M19.72%4.09M91.85%3.25M959.96%11.97M449.43%3.37M818.95%3.49M2,587.40%3.41M18,722.22%1.69M5,031.82%1.13M20,333.33%613K
Non-operating interest income 9.94%3.84M19.72%4.09M91.85%3.25M959.96%11.97M449.43%3.37M818.95%3.49M2,587.40%3.41M18,722.22%1.69M5,031.82%1.13M20,333.33%613K
Other net income (expense) 661.54%73K799K-1K-22K-9K-13K
Special income (charges) --73K--800K--------------0--0------------
-Less：Restructuring and merger&acquisition ---73K---800K--------------0--0------------
Other non- operating income (expenses) -------1K---1K---22K---9K---13K----------------
Income before tax -11.49%-23.16M-17.92%-19.72M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M-52.23%-37.66M-13.80%-9.55M
Income tax 0232K00
Net income -11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M-52.23%-37.66M-13.80%-9.55M
Net income continuous Operations -11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M-52.23%-37.66M-13.80%-9.55M
Minority interest income
Net income attributable to the parent company -11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M-52.23%-37.66M-13.80%-9.55M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M-52.23%-37.66M-13.80%-9.55M
Basic earnings per share 5.88%-0.480.00%-0.4132.50%-0.54-119.35%-2.01-97.97%-0.46-98.61%-0.51-89.57%-0.41-279.28%-0.8-52.23%-0.9164-13.80%-0.2324
Diluted earnings per share 5.88%-0.480.00%-0.4132.50%-0.54-119.35%-2.01-97.97%-0.46-98.61%-0.51-89.57%-0.41-279.28%-0.8-52.23%-0.9164-13.80%-0.2324
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
Hanshow Technology
301275
+143.35%
Yong Jie New Material
603271
+124.42%
ZZT
873726
+29.99%
4
BEOKA
870199
+23.76%
5
Geovis Insighter Technology
920116
+21.91%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
As China's 'two sessions' commence: How will Chinese stocks perform?
🎙️Discussion 1. With the government's emphasis on technological innovation and sustainability, which industry sectors do you believe hold t Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings